Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Malignant Lymphoma

  Free Subscription


2 Am J Hematol
3 Blood
1 BMC Cancer
1 Bone Marrow Transplant
5 Br J Haematol
2 Haematologica
1 J Am Acad Dermatol
3 Leuk Lymphoma
1 N Engl J Med
1 Neurology
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Hematol

  1. MONDELLO P, Musolino C, Dogliotti I, Bohn JP, et al
    ABVD vs BEACOPP escalated in Advanced-Stage Hodgkin's Lymphoma: results from a multicenter European study.
    Am J Hematol. 2020 May 17. doi: 10.1002/ajh.25871.
    PubMed         Abstract available

  2. ZANWAR S, Abeykoon JP, Durot E, King R, et al
    Impact of MYD88(L265P) mutation status on histological transformation of Waldenstrom Macroglobulinemia.
    Am J Hematol. 2020;95:274-281.
    PubMed         Abstract available


  3. GAYDOSIK AM, Queen DS, Trager MH, Akilov OE, et al
    Genome-wide transcriptome analysis of the STAT6-regulated genes in advanced-stage cutaneous T-cell lymphoma.
    Blood. 2020 May 21. pii: 456039. doi: 10.1182/blood.2019004725.
    PubMed         Abstract available

  4. MCGINNIS E, Farinha P
    Intravascular large B-cell lymphoma presenting with acute encephalopathy.
    Blood. 2020;135:1916.

    Sensitizing Burkitt lymphoma to EBV-CTLs.
    Blood. 2020;135:1822-1823.

    BMC Cancer

  6. GO SI, Kim HG, Kang MH, Park S, et al
    Prognostic model based on the geriatric nutritional risk index and sarcopenia in patients with diffuse large B-cell lymphoma.
    BMC Cancer. 2020;20:439.
    PubMed         Abstract available

    Bone Marrow Transplant

  7. SUREDA A, Genadieva Stavrik S, Boumendil A, Finel H, et al
    Changes in patients population and characteristics of hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma: an analysis of the Lymphoma Working Party of the EBMT.
    Bone Marrow Transplant. 2020 May 15. pii: 10.1038/s41409-020-0929.
    PubMed         Abstract available

    Br J Haematol

  8. BADAR T, Astle J, Kakar IK, Zellner K, et al
    Clinical activity of ibrutinib in classical Hodgkin lymphoma relapsing after allogeneic stem cell transplantation is independent of tumor BTK expression.
    Br J Haematol. 2020 May 16. doi: 10.1111/bjh.16738.

  9. SHIVAROV V, Ivanova M
    Clinical outcomes of composite and sequential B-cell lymphomas with features intermediate between DLBCL/PMBCL and classical Hodgkin Lymphoma from the SEER database.
    Br J Haematol. 2020 May 18. doi: 10.1111/bjh.16728.

  10. CARREAU NA, Armand P, Merryman RW, Advani RH, et al
    Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapy.
    Br J Haematol. 2020 May 19. doi: 10.1111/bjh.16756.
    PubMed         Abstract available

  11. MCKAY P, Wilson MR, Chaganti S, Smith J, et al
    The prevention of central nervous system relapse in diffuse large B-cell lymphoma: a British Society for Haematology Good Practice Paper.
    Br J Haematol. 2020 May 20. doi: 10.1111/bjh.16866.
    PubMed         Abstract available

  12. GLEESON M, Counsell N, Cunningham D, Lawrie A, et al
    Prognostic indices in diffuse large B-cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R-CHOP 14 versus 21 phase 3 trial.
    Br J Haematol. 2020 May 20. doi: 10.1111/bjh.16691.
    PubMed         Abstract available


  13. OISHI N, Hundal T, Phillips JL, Dasari S, et al
    Molecular profiling reveals a hypoxia signature in breast implant-associated anaplastic large cell lymphoma.
    Haematologica. 2020 May 15. pii: haematol.2019.245860.
    PubMed         Abstract available

  14. WANG Z, Gong Q, Zhao Y, Xu H, et al
    Indolent EBV-positive T-cell lymphoproliferative disorder arising in a chronic pericardial hematoma: the T-cell counterpart of fibrin-associated diffuse large B-cell lymphoma?
    Haematologica. 2020 May 15. pii: haematol.2020.252007.

    J Am Acad Dermatol

  15. ELLIS A, Christensen LF, Sharma T, Meyerson H, et al
    CD30 positive Leukemic Cutaneous T Cell Lymphoma.
    J Am Acad Dermatol. 2020 May 10. pii: S0190-9622(20)30841.

    Leuk Lymphoma

  16. MARCHESI F, Capria S, Pedata M, Terrenato I, et al
    BEAM conditioning regimen ensures better progression-free survival compared with TEAM but not with FEAM in lymphoma patients undergoing autologous stem cell transplant.
    Leuk Lymphoma. 2020 May 18:1-4. doi: 10.1080/10428194.2020.1765238.

  17. PICKARD L, Palladino G, Okosun J
    Follicular lymphoma genomics.
    Leuk Lymphoma. 2020 May 19:1-11. doi: 10.1080/10428194.2020.1762883.
    PubMed         Abstract available

  18. KNEZ V, Bao L, Carstens B, Liang X, et al
    Analysis of clinicopathological and cytogenetic differences between B-lymphoblastic lymphoma and B-lymphoblastic leukemia in childhood.
    Leuk Lymphoma. 2020 May 19:1-7. doi: 10.1080/10428194.2020.1761970.
    PubMed         Abstract available

    N Engl J Med

    CAR-Transduced Natural Killer Cells.
    N Engl J Med. 2020;382:1866.


  20. KRAUSE MA, English SW, Zalewski NL
    Clinical Reasoning: A 70-year-old man with rapid stepwise paraparesis and sensory loss.
    Neurology. 2020;94:e651-e655.

    PLoS One

  21. MAESTRE L, Garcia-Garcia JF, Jimenez S, Reyes-Garcia AI, et al
    High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations.
    PLoS One. 2020;15:e0229743.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.